On July 9, 2021, President Biden signed a far-reaching Executive Order that could have significant impact on the healthcare industry. Under the Executive Order, President Biden:
– Encourages the Federal Trade Commission to ban or limit noncompete agreements, and to ban unnecessary occupational licensing restrictions;
– Supports the practice of state and tribal programs importing drugs from Canada;
– Directs HHS to increase support for generic and biosimilar drugs, and to issue a comprehensive plan to, “combat high prescription drug prices and price gouging” within 45 days;Continue reading
